Displaying 8851 - 8900 of 14716 results
Released Company Title Industry Topic
13 Dec 2021
17:41 CET
BEFIMMO Befimmo SA: Update regarding the liquidity contract 35102030 Office REITs Other subject
13 Dec 2021
17:41 CET
BEFIMMO Befimmo SA: Etat du programme de liquidité 35102030 Office REITs Other subject
13 Dec 2021
17:40 CET
AGFA-GEVAERT Agfa-Gevaert: Aandeleninkoopprogramma – gereglementeerde informatie 50202025 Electronic Equipment: Gauges and Meters Other subject
13 Dec 2021
17:40 CET
AGEAS Ageas rapporteert over de inkoop van eigen aandelen 30301010 Life Insurance Other financial transaction
13 Dec 2021
17:40 CET
AGEAS Ageas reports on the progress of share buy-back programme 30301010 Life Insurance Other financial transaction
13 Dec 2021
17:40 CET
AGFA-GEVAERT Agfa-Gevaert: Share buyback program – regulated information 50202025 Electronic Equipment: Gauges and Meters Other subject
13 Dec 2021
17:40 CET
AGEAS Rapport d’Ageas sur le programme de rachat d’actions 30301010 Life Insurance Other financial transaction
13 Dec 2021
09:25 CET
SHURGARD 20211213 Shurgard opens new self storage property in London Bow 35101010 Real Estate Holding and Development Mergers, Acquiqitions, Transferts
13 Dec 2021
08:40 CET
TITAN CEMENT Programme de rachats d'actions 50101030 Cement Other subject
13 Dec 2021
08:39 CET
TITAN CEMENT Share buyback programme 50101030 Cement Other subject
13 Dec 2021
07:01 CET
CELYAD ONCOLOGY Celyad Oncology présente des mises à jour sur les programmes CAR-T basés sur la technologie ARNsh lors de la 63e assemblée et exposition annuelles de l’ASH 20103010 Biotechnology Other subject
13 Dec 2021
07:01 CET
CELYAD ONCOLOGY Celyad Oncology Presents Updates on shRNA-Based CAR T Programs at the 63rd ASH Annual Meeting and Exposition 20103010 Biotechnology Other subject
13 Dec 2021
07:00 CET
ACACIA PHARMA Acacia Pharma Announces Successful Completion of BARHEMSYS® Post-approval Requirement Study in Patients with Severe Renal Impairment 20103010 Biotechnology Other subject
13 Dec 2021
07:00 CET
FAGRON Save the date Fagron Capital Markets Day 2022 20102010 Medical Equipment Meetings / events
13 Dec 2021
07:00 CET
FAGRON Save the date Capital Markets Day 2022 van Fagron 20102010 Medical Equipment Meetings / events
11 Dec 2021
00:01 CET
MDXHEALTH MDxHealth Shareholder Transparency Declaration 20103010 Biotechnology Share history
11 Dec 2021
00:01 CET
MDXHEALTH Déclaration de transparence d'un actionnaire de MDxHealth 20103010 Biotechnology Share history
10 Dec 2021
19:00 CET
BANIMMO A Banimmo confirme mener des négociations exclusives avec la Régie des Bâtiments pour la vente de NETWORKS NØR 35101010 Real Estate Holding and Development Mergers, Acquiqitions, Transferts
10 Dec 2021
19:00 CET
BANIMMO A Banimmo bevestigt in exclusieve onderhandeling te zijn met de Regie der Gebouwen voor de verkoop van NETWORKS NØR 35101010 Real Estate Holding and Development Mergers, Acquiqitions, Transferts
10 Dec 2021
08:00 CET
BEKAERT Bekaert - Aan- en verkoop van aandelen in het kader van het liquiditeitscontract 55102010 Iron and Steel Legal
10 Dec 2021
08:00 CET
BEKAERT Bekaert - Purchase and sale of shares in the context of the liquidity agreement 55102010 Iron and Steel Legal
10 Dec 2021
08:00 CET
BEKAERT Bekaert - Achat et vente d’actions dans le cadre du contrat de liquidité 55102010 Iron and Steel Legal
10 Dec 2021
07:00 CET
BONE THERAPEUTICS Bone Therapeutics SA: Transparency notification received from Nyenburgh Holding NV 20103010 Biotechnology Corporate life
10 Dec 2021
07:00 CET
BONE THERAPEUTICS Bone Therapeutics SA : Notification de transparence reçue de la part de Nyenburgh Holding NV 20103010 Biotechnology Corporate life
09 Dec 2021
19:00 CET
VGP VGP NV: Disclosure in Accordance with the Law of 2 May 2007 - Transparency Law: Transparency Notification by Mr Jan Van Geet 35101010 Real Estate Holding and Development Change in Capital
09 Dec 2021
19:00 CET
VGP VGP NV: Openbaarmaking Conform de Wet van 2 mei 2007 - Transparantiewetgeving: Transparantiekennisgeving door Dhr. Jan Van Geet 35101010 Real Estate Holding and Development Change in Capital
09 Dec 2021
18:30 CET
IEP INVEST Rechtzetting met betrekking tot de aanpassing van het schema voor de uitkering van een interim-dividend 35101010 Real Estate Holding and Development Dividend
09 Dec 2021
18:00 CET
INTERVEST OFF-WARE Intervest Offices & Warehouses NV verlengt huurovereenkomsten op lange termijn met klanten in logistiek segment in Nederland 35102030 Office REITs News contracts
09 Dec 2021
18:00 CET
INTERVEST OFF-WARE Intervest Offices & Warehouses NV extends lease agreements for the long term with customers in the logistics segment in the Netherlands 35102030 Office REITs News contracts
09 Dec 2021
18:00 CET
ACCENTIS Overeenkomst m.b.t. verkoop aandelen Accentis Námestovo s.r.o. 35101010 Real Estate Holding and Development Mergers, Acquiqitions, Transferts
09 Dec 2021
18:00 CET
INTERVEST OFF-WARE Intervest Offices & Warehouses SA prolonge les contrats à long terme avec des clients dans le segment logistique aux Pays-Bas 35102030 Office REITs News contracts
09 Dec 2021
17:45 CET
CRESCENT GEREGLEMENTEERDE INFORMATIE - Openbaarmaking over een transparantiekennisgeving (artikel 14, eerste lid, van de wet van 2 mei 2007 op de openbaarmaking van belangrijke deelnemingen) 15101010 Telecommunications Equipment Other subject
09 Dec 2021
17:45 CET
CRESCENT REGULATED INFORMATION Disclosure of a transparency notification (Article 14(1) of the Law of 2 May 2007 on disclosure of major holdings) 15101010 Telecommunications Equipment Other subject
09 Dec 2021
08:00 CET
EURONAV Carbon Disclosure Project confirms ‘B’ score for Euronav for actions against climate change 50206030 Marine Transportation Other subject
09 Dec 2021
08:00 CET
EURONAV Carbon Disclosure Project bevestigt ‘B’ score voor Euronav voor acties tegen klimaatverandering 50206030 Marine Transportation Other subject
09 Dec 2021
07:00 CET
BONE THERAPEUTICS Bone Therapeutics SA : Information relative au nombre total de droits de vote et d’actions 20103010 Biotechnology Change in Capital
09 Dec 2021
07:00 CET
BIOCARTIS Persbericht Biocartis Group NV: Biocartis’ Idylla™ SARS-CoV-2 testing detecteert met succes de omicron variant 20101025 Health Services Commercial results
09 Dec 2021
07:00 CET
BONE THERAPEUTICS Bone Therapeutics SA: Information on the total number of voting rights and shares 20103010 Biotechnology Change in Capital
09 Dec 2021
07:00 CET
BIOCARTIS Press release Biocartis Group NV: Biocartis’ Idylla™ SARS-CoV-2 testing Successfully Detects Omicron Variant 20101025 Health Services Commercial results
08 Dec 2021
22:02 CET
CELYAD ONCOLOGY Celyad Oncology annonce la clôture du placement privé de 32,5 millions USD souscrit par une filiale de Fortress Investment Group 20103010 Biotechnology Other financial transaction
08 Dec 2021
22:02 CET
CELYAD ONCOLOGY Celyad Oncology Announces Closing of $32.5 Million Private Placement with Fortress Investment Group Affiliate 20103010 Biotechnology Other financial transaction
08 Dec 2021
17:40 CET
NEXTENSA NEXTENSA SA :  RACHAT D’ACTIONS 35102030 Office REITs Other subject
08 Dec 2021
17:40 CET
NEXTENSA NEXTENSA NV : INKOOP EIGEN AANDELEN 35102030 Office REITs Other subject
08 Dec 2021
17:40 CET
NEXTENSA Nextensa Nv/sa: Shares Repurchase 35102030 Office REITs Other subject
08 Dec 2021
08:00 CET
UMICORE Umicore en Volkswagen AG richten Europese joint venture voor EV-batterijmaterialen op 55201020 Specialty Chemicals New
08 Dec 2021
08:00 CET
UMICORE Umicore and Volkswagen AG to create European EV battery materials Joint Venture 55201020 Specialty Chemicals New
08 Dec 2021
08:00 CET
CARE PROPERTY INVEST Care Property Invest kondigt de inkoop van eigen aandelen aan 35102040 Residential REITs Other financial transaction
08 Dec 2021
08:00 CET
UMICORE Umicore et Volkswagen AG créent une coentreprise européenne de matériaux pour batterie de véhicules électriques 55201020 Specialty Chemicals New
08 Dec 2021
08:00 CET
CARE PROPERTY INVEST Repurchase of own shares 35102040 Residential REITs Other financial transaction
08 Dec 2021
07:00 CET
BONE THERAPEUTICS Bone Therapeutics announces closing of private placement 20103010 Biotechnology Share introduction and issues